Key result
In patients with type 2 diabetes, a disease duration of 7.5 years or longer was strongly associated with the development of cardiac autonomic neuropathy.
Why the study?
Cardiovascular autonomic neuropathy is an underdiagnosed complication of type 2 diabetes and an independent risk factor for cardiovascular mortality and events, prompting evaluation of autonomic activity and associated risk factors.
Cross-Sectional (n=242)
Yes
In patients with type 2 diabetes, poorer glycemic control and longer disease duration are strongly associated with a higher prevalence and severity of cardiovascular autonomic neuropathy.
Answers are grounded in this paper and cite their sources.
May support targeted cardiac autonomic neuropathy screening after 7.5 years of type 2 diabetes; leaves open causality and prevention effects.
The impairment of cardiovascular autonomic control among the underdiagnosed complication of diabetes mellitus (DM) with a high prevalence rate of up to 60% in type 2 DM (T2DM). Cardiac autonomic neuropathy (CAN) is an independent risk factor for cardiovascular mortality, arrhythmia, silent ischemia, any major cardiovascular event, and heart failure. We aimed to evaluate cardiovascular autonomic activity by different physiological maneuvers, study risk factors for diabetic CAN including age, gender, duration of diabetes, body mass index (BMI), and glycemic control, and correlate CAN stage with risk factors. One hundred and forty-two T2DM patients consisted of 62 males and 80 females and 100 volunteers as a control sample. Cardiac autonomic functions were assessed by Ewing's tests. Glycated hemoglobin (HbA1c), body weight, height, body mass index (BMI), and waist-hip ratio (WHR) were also measured. Cardiovascular autonomic functions and Ewing scores were significantly different in people with diabetes when compared with control healthy subjects. Ewings test values and Ewing scores were significantly different between diabetics with and without CAN and within patients with different CAN staging. People with diabetes with CAN have a significantly longer duration of disease when compared to those without CAN. A strong association has been found between CAN severity and patient age, duration of disease, HbA1c severity, and the WHR (P < 0.001) but not with BMI. The duration of disease and HbA1c level appear to be associated with the development of CAN (P = 0.001 and P = 0.008, respectively). The poorer glycemic control and the longer the duration of the disease, the higher the prevalence of CAN in T2DM. Age, duration of disease, WHR, and HbA1c are well correlated with the severity of CAN. Parasympathetic impairment is more sensitive to the detection of autonomic dysfunctions than do sympathetic impairment.
No takes yet. Share an insight, caveat, or question.
Dhumad et al. (2021) conducted a cross-sectional in Type 2 Diabetes Mellitus and Cardiac Autonomic Neuropathy (n=242). Diabetes duration ≥ 7.5 years vs. Diabetes duration < 7.5 years was evaluated on Development of cardiac autonomic neuropathy (CAN) (OR 10.63, 95% CI 2.56-44.06, p=0.001). In patients with type 2 diabetes, a disease duration of 7.5 years or longer was strongly associated with the development of cardiac autonomic neuropathy.
Synapse has enriched 10 related papers. Consider them for comparative context: